Telemus Capital’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $503K | Sell |
3,045
-75
| -2% | -$12.4K | 0.04% | 239 |
|
|
2023
Q3 | $486K | Hold |
3,120
| – | – | 0.05% | 219 |
|
|
2023
Q2 | $487K | Sell |
3,120
-30
| -1% | -$4.68K | 0.04% | 228 |
|
|
2023
Q1 | $511K | Sell |
3,150
-27
| -0.8% | -$4.38K | 0.05% | 217 |
|
|
2022
Q4 | $517K | Buy |
3,177
+27
| +0.9% | +$4.39K | 0.05% | 222 |
|
|
2022
Q3 | $443K | Sell |
3,150
-88
| -3% | -$12.4K | 0.05% | 213 |
|
|
2022
Q2 | $472K | Buy |
3,238
+88
| +3% | +$12.8K | 0.05% | 240 |
|
|
2022
Q1 | $511K | Buy |
3,150
+5
| +0.2% | +$811 | 0.04% | 227 |
|
|
2021
Q4 | $595K | Hold |
3,145
| – | – | 0.05% | 228 |
|
|
2021
Q3 | $636K | Buy |
3,145
+10
| +0.3% | +$2.02K | 0.05% | 214 |
|
|
2021
Q2 | $632K | Buy |
3,135
+65
| +2% | +$13.1K | 0.05% | 225 |
|
|
2021
Q1 | $545K | Buy |
3,070
+20
| +0.7% | +$3.55K | 0.04% | 263 |
|
|
2020
Q4 | $518K | Buy |
3,050
+125
| +4% | +$21.2K | 0.04% | 248 |
|
|
2020
Q3 | $477K | Sell |
2,925
-34
| -1% | -$5.55K | 0.04% | 306 |
|
|
2020
Q2 | $495K | Sell |
2,959
-100
| -3% | -$16.7K | 0.04% | 276 |
|
|
2020
Q1 | $492K | Sell |
3,059
-1,511
| -33% | -$243K | 0.04% | 254 |
|
|
2019
Q4 | $637K | Buy |
4,570
+40
| +0.9% | +$5.58K | 0.05% | 222 |
|
|
2019
Q3 | $534K | Hold |
4,530
| – | – | 0.04% | 236 |
|
|
2019
Q2 | $554K | Sell |
4,530
-425
| -9% | -$52K | 0.05% | 225 |
|
|
2019
Q1 | $637K | Hold |
4,955
| – | – | 0.05% | 243 |
|
|
2018
Q4 | $549K | Hold |
4,955
| – | – | 0.04% | 256 |
|
|
2018
Q3 | $674K | Hold |
4,955
| – | – | 0.05% | 259 |
|
|
2018
Q2 | $595K | Buy |
+4,955
| New | +$595K | 0.05% | 268 |
|
|
2018
Q1 | – | Sell |
-1,030
| Closed | -$128K | – | 417 |
|
|
2017
Q4 | $128K | Buy |
+1,030
| New | +$128K | 0.01% | 411 |
|